Cocrystal Pharma, Inc. (COCP) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 5.94M | 8.13M | 8.78M | 6.76M | 8.83M | 11.58M | 14.26M | 19.66M | 24.49M | 29.09M | 32.2M | 35.76M | 37.24M | 40.18M | 44.9M | 51.6M | 55.4M | 59.32M | 62.44M | 67.34M |
| Cash & Short-Term Investments | 4.68M | 7.03M | 7.73M | 4.77M | 6.92M | 9.86M | 13.02M | 18.14M | 21.84M | 26.35M | 29.74M | 32.49M | 33.98M | 37.14M | 42.06M | 51.03M | 54.79M | 58.7M | 61.64M | 67.06M |
| Cash Only | 4.68M | 7.03M | 7.73M | 4.77M | 6.92M | 9.86M | 13.02M | 18.14M | 21.84M | 26.35M | 29.74M | 32.49M | 33.98M | 37.14M | 42.06M | 51.03M | 54.79M | 58.7M | 61.64M | 67.06M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 761K | 706K | 513K | 1.64M | 1.45M | 1.22M | 652K | 1.08M | 1M | 890K | 0 | 1.21M | 956K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 293.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | 1.73 | - | - | - | - | - | - | - |
| Other Current Assets | 493K | 403K | 540K | 357K | 460K | 505K | 75K | 440K | 1.65M | 1.85M | 625K | 2.06M | 2.22M | 2.49M | 75K | 75K | 50K | 50K | 125K | 50K |
| Total Non-Current Assets | 1.49M | 1.58M | 1.66M | 1.74M | 1.83M | 1.88M | 1.98M | 1.91M | 2.05M | 2.17M | 409K | 518K | 605K | 662K | 751K | 787K | 19.97M | 20.07M | 20.16M | 20.08M |
| Property, Plant & Equipment | 1.39M | 1.48M | 1.57M | 1.65M | 1.75M | 1.85M | 1.95M | 1.88M | 2.01M | 2.12M | 363K | 472K | 559K | 616K | 705K | 741K | 835K | 931K | 1.02M | 942K |
| Fixed Asset Turnover | 0.16x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.09M | 19.09M | 19.09M | 19.09M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 95K | 95K | 90K | 88K | 86K | 29K | 29K | 29K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 46K |
| Total Assets | 7.43M | 9.71M | 10.45M | 8.51M | 10.66M | 13.46M | 16.23M | 21.57M | 26.55M | 31.26M | 32.61M | 36.28M | 37.84M | 40.84M | 45.65M | 52.38M | 75.37M | 79.39M | 82.6M | 87.42M |
| Asset Turnover | 0.03x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -30.33% | -27.82% | -35.65% | -60.58% | -59.85% | -56.95% | -50.23% | -40.54% | -29.85% | -23.46% | -28.55% | -30.74% | -49.79% | -48.56% | -44.74% | -40.08% | 39.96% | 46.37% | 55.21% | 115.96% |
| Total Current Liabilities | 2.23M | 2.21M | 1.52M | 1.83M | 1.93M | 2.43M | 1.95M | 2.65M | 2.38M | 3.26M | 1.92M | 1.59M | 3.15M | 1.22M | 1.62M | 2.81M | 1.56M | 1.54M | 1.23M | 2.38M |
| Accounts Payable | 1.37M | 890K | 745K | 856K | 808K | 1.54M | 859K | 1.74M | 1.23M | 1.22M | 568K | 1.04M | 2.65M | 614K | 897K | 616K | 858K | 578K | 491K | 939K |
| Days Payables Outstanding | 1.12K | -53.95 | - | 3.61K | 77.76 | 3.94K | 36.92 | 31.44 | 37.88 | 19.3 | 17.65 | 60.02 | 37.64 | 21.15 | 17.97 | 28.41 | 22.5 | 506.95 | 31.25 | 30.02 |
| Short-Term Debt | 343K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 166K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 515K | 986K | 322K | 106K | 100K | 0 | 185K | 156K | 139K | 1.69M | 0 | 230K | 0 | 0 | 165K | 144K | 1K | 116K | 34K | 185K |
| Current Ratio | 2.66x | 3.68x | 5.78x | 3.69x | 4.57x | 4.77x | 7.32x | 7.41x | 10.30x | 8.92x | 16.74x | 22.53x | 11.84x | 33.04x | 27.73x | 18.34x | 35.56x | 38.40x | 50.85x | 28.30x |
| Quick Ratio | 2.66x | 3.68x | 5.78x | 3.69x | 4.57x | 4.77x | 7.32x | 7.41x | 10.30x | 8.92x | 16.74x | 22.53x | 11.82x | 33.04x | 27.73x | 18.34x | 35.56x | 38.40x | 50.85x | 28.30x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.08M | 1.17M | 1.26M | 1.34M | 1.42M | 1.5M | 1.58M | 1.53M | 1.58M | 1.61M | 0 | 10K | 27K | 57K | 119K | 177K | 234K | 298K | 358K | 290K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.08M | 1.17M | 1.26M | 1.34M | 1.42M | 1.5M | 1.58M | 1.53M | 1.58M | 1.61M | 0 | 10K | 27K | 57K | 119K | 177K | 234K | 298K | 358K | 290K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.31M | 3.38M | 2.78M | 3.17M | 3.35M | 3.93M | 3.53M | 4.18M | 3.96M | 4.88M | 1.92M | 1.6M | 3.17M | 1.27M | 1.74M | 2.99M | 1.79M | 1.84M | 1.59M | 2.67M |
| Total Debt | 1.42M | 1.5M | 1.58M | 1.66M | 1.73M | 1.81M | 1.88M | 1.78M | 1.82M | 1.85M | 118K | 176K | 235K | 297K | 360K | 419K | 477K | 534K | 591K | 480K |
| Net Debt | -3.26M | -5.52M | -6.15M | -3.11M | -5.19M | -8.05M | -11.14M | -16.36M | -20.02M | -24.5M | -29.62M | -32.32M | -33.75M | -36.85M | -41.7M | -50.61M | -54.31M | -58.17M | -61.05M | -66.58M |
| Debt / Equity | 0.35x | 0.24x | 0.21x | 0.31x | 0.24x | 0.19x | 0.15x | 0.10x | 0.08x | 0.07x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | -65.53x | -4502.00x | -5694.00x | - | -4205.00x | - | -3953.00x | -1914.00x |
| Total Equity | 4.12M | 6.33M | 7.67M | 5.33M | 7.3M | 9.52M | 12.7M | 17.39M | 22.59M | 26.38M | 30.69M | 34.68M | 34.67M | 39.57M | 43.91M | 49.39M | 73.58M | 77.55M | 81.01M | 84.75M |
| Equity Growth % | -43.65% | -33.52% | -39.63% | -69.33% | -67.66% | -63.91% | -58.61% | -49.86% | -34.86% | -33.32% | -30.11% | -29.78% | -52.88% | -48.98% | -45.8% | -41.72% | 41.34% | 47.7% | 61.45% | 128.71% |
| Book Value per Share | 0.30 | 0.56 | 0.70 | 0.52 | 0.72 | 0.94 | 1.25 | 1.71 | 2.22 | 2.59 | 3.02 | 3.45 | 4.26 | 4.86 | 5.39 | 6.08 | 9.06 | 10.69 | 9.95 | 11.68 |
| Total Shareholders' Equity | 4.12M | 6.33M | 7.67M | 5.33M | 7.3M | 9.52M | 12.7M | 17.39M | 22.59M | 26.38M | 30.69M | 34.68M | 34.67M | 39.57M | 43.91M | 49.39M | 73.58M | 77.55M | 81.01M | 84.75M |
| Common Stock | 13K | 13K | 13K | 10K | 10K | 10K | 10K | 10K | 10K | 10K | 10K | 10K | 8K | 8K | 8K | 98K | 98K | 8K | 98K | 98K |
| Retained Earnings | -344.55M | -342.25M | -339.82M | -337.77M | -335.72M | -333.42M | -330.15M | -325.21M | -319.87M | -315.91M | -311.45M | -307.29M | -303.12M | -297.93M | -293.43M | -287.73M | -263.3M | -259.09M | -255.41M | -251.47M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |